JP2014534173A5 - - Google Patents

Download PDF

Info

Publication number
JP2014534173A5
JP2014534173A5 JP2014532400A JP2014532400A JP2014534173A5 JP 2014534173 A5 JP2014534173 A5 JP 2014534173A5 JP 2014532400 A JP2014532400 A JP 2014532400A JP 2014532400 A JP2014532400 A JP 2014532400A JP 2014534173 A5 JP2014534173 A5 JP 2014534173A5
Authority
JP
Japan
Prior art keywords
xaa
compound
lysine
compound according
hydroxylysine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014532400A
Other languages
English (en)
Japanese (ja)
Other versions
JP6158188B2 (ja
JP2014534173A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/069166 external-priority patent/WO2013045600A1/en
Publication of JP2014534173A publication Critical patent/JP2014534173A/ja
Publication of JP2014534173A5 publication Critical patent/JP2014534173A5/ja
Application granted granted Critical
Publication of JP6158188B2 publication Critical patent/JP6158188B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014532400A 2011-09-28 2012-09-28 抗生物質としての新規なペプチド誘導体 Active JP6158188B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161540085P 2011-09-28 2011-09-28
EP11183034.5 2011-09-28
EP11183034 2011-09-28
US61/540,085 2011-09-28
PCT/EP2012/069166 WO2013045600A1 (en) 2011-09-28 2012-09-28 Novel peptide derivatives as antibiotics

Publications (3)

Publication Number Publication Date
JP2014534173A JP2014534173A (ja) 2014-12-18
JP2014534173A5 true JP2014534173A5 (enExample) 2015-11-19
JP6158188B2 JP6158188B2 (ja) 2017-07-05

Family

ID=47994311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014532400A Active JP6158188B2 (ja) 2011-09-28 2012-09-28 抗生物質としての新規なペプチド誘導体

Country Status (10)

Country Link
US (1) US9260481B2 (enExample)
EP (1) EP2760881B1 (enExample)
JP (1) JP6158188B2 (enExample)
CN (1) CN103827138B (enExample)
CA (1) CA2845735A1 (enExample)
ES (1) ES2657930T3 (enExample)
IL (1) IL231664A0 (enExample)
IN (1) IN2014DN03010A (enExample)
RU (1) RU2014114996A (enExample)
WO (1) WO2013045600A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106715460B (zh) * 2014-09-26 2022-04-08 诺索药业公司 新型肽衍生物及其用途
US9800971B2 (en) 2015-03-17 2017-10-24 Knowles Electronics, Llc Acoustic apparatus with side port
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
WO2024200838A1 (en) * 2023-03-31 2024-10-03 Nosopharm New odilorhabdins analogues as antibiotics against multi-resistant bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717299D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Peptides
FR2819514B1 (fr) * 2001-01-12 2003-02-28 Rhobio Pseudopeptides antimicrobiens
WO2010129033A2 (en) * 2009-04-29 2010-11-11 Calmune Corporation Modified antibodies for passive immunotherapy
FR2946058A1 (fr) * 2009-05-27 2010-12-03 Nosopharm Procede pour augmenter la diversite des metabolites secondaires d'interet produits par des micro-organismes

Similar Documents

Publication Publication Date Title
JP2014534173A5 (enExample)
JP2012504133A5 (enExample)
MX342377B (es) Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico.
CL2011003192A1 (es) Acido (2s)-3-(2-fluoro-5-(5-fluoro-1h-pirrolo[2,3-b]piridin-3-il)fenilamino)biciclo[2.2.2]octano-2-carboxilico; metodo para prepararlo; composicion farmaceutica que lo comprende; y su uso en el tratamiento de la influenza; metodo para reducir el virus de la influenza in vitro.
WO2011079142A3 (en) Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
RU2014112343A (ru) Оставы антигенов staphylococcus aureus, содержащие адъюванты
JP2011500769A5 (enExample)
EP2590655A4 (en) COMPOUNDS AND METHOD FOR INHIBITING PHOSPHATE TRANSPORT
JP2013047268A5 (enExample)
RU2013149168A (ru) Аналоги эпоксиэйкозатриеновой кислоты и способы их получения и использования
WO2009026446A8 (en) Hdac inhibitors
MX2010009395A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procesos para preparacion de los mismos.
MX368157B (es) Formulaciones de sal de meglumina del acido 1-(5,6-dicloro-1h-benz o[d]imidazol-2-il)-1h-pirazol-4-carboxilico.
JO3611B1 (ar) سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
NZ601559A (en) Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
EP2576576A4 (en) HETEROCYCLYL-PYRIDINYL BASE PHOSPHONIC ACID, PHARMACEUTICALLY ALLOWED SALT, COMPOSITION, AND METHOD OF USE THEREOF
JP2012522841A5 (enExample)
RU2015122032A (ru) Оксазолидинонсодержащие соединения, композиции и способы их использования
TW200942529A (en) Pyrrolidinyl derivatives and uses thereof
MX2010009756A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos.
RU2014114996A (ru) Новые пептидные производные в качестве антибиотиков
JP2011508779A5 (enExample)
WO2010036567A3 (en) Harmine compounds for promoting bone growth
JP2013509378A5 (enExample)
JP2013505719A5 (enExample)